Emerging preclinical studies suggest that Hp-OMVs may translocate across epithelial barriers and reach distant organs, including the brain, where they have been shown to exacerbate neuroinflammatory responses in murine models of Alzheimer's disease. The gene discussed is HP; the disease is early-onset autosomal dominant Alzheimer disease.